How did SNOA's Q3 2025 EPS forecast compare to past trends?

Sonoma Pharmaceuticals (SNOA) Q3 2025 EPS forecast was not available, but looking at the trend of the EPS over the past few years, it has been declining. From Q2 2025 to Q3 2025, the EPS declined by 6.78%. Additionally, the EPS in Q3 2025 was $-0.59, which is higher than the EPS in Q2 2025, $-1.40. However, when comparing the EPS in Q3 2025 with the previous quarter, the EPS decreased by 7.2%. |code|Ticker|Name|Date|Diluted EPS QoQ|Diluted EPS|market_code| |---|---|---|---|---|---|---| |SNOA|SNOA.O|Sonoma Pharmaceuticals|2025 Q1||-0.07|186| |SNOA|SNOA.O|Sonoma Pharmaceuticals|2025 Q2|-742.8571428571428|-0.59|186| |SNOA|SNOA.O|Sonoma Pharmaceuticals|2025 Q3|-6.779661016949159|-0.63|186|